Severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab

Detalles Bibliográficos
Autores principales: Menteşoğlu, Dilek, Günaydin, Sibel Doğan, Ersoy-Evans, Sibel, Atakan, Nilgün, Gököz, Özay, Karadağ, Ömer, Kılıçkap, Saadettin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804122/
https://www.ncbi.nlm.nih.gov/pubmed/36204814
http://dx.doi.org/10.4103/ijp.ijp_11_22
_version_ 1784862034072961024
author Menteşoğlu, Dilek
Günaydin, Sibel Doğan
Ersoy-Evans, Sibel
Atakan, Nilgün
Gököz, Özay
Karadağ, Ömer
Kılıçkap, Saadettin
author_facet Menteşoğlu, Dilek
Günaydin, Sibel Doğan
Ersoy-Evans, Sibel
Atakan, Nilgün
Gököz, Özay
Karadağ, Ömer
Kılıçkap, Saadettin
author_sort Menteşoğlu, Dilek
collection PubMed
description
format Online
Article
Text
id pubmed-9804122
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-98041222023-01-01 Severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab Menteşoğlu, Dilek Günaydin, Sibel Doğan Ersoy-Evans, Sibel Atakan, Nilgün Gököz, Özay Karadağ, Ömer Kılıçkap, Saadettin Indian J Pharmacol Letter to the Editor Wolters Kluwer - Medknow 2022 2022-10-06 /pmc/articles/PMC9804122/ /pubmed/36204814 http://dx.doi.org/10.4103/ijp.ijp_11_22 Text en Copyright: © 2022 Indian Journal of Pharmacology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Letter to the Editor
Menteşoğlu, Dilek
Günaydin, Sibel Doğan
Ersoy-Evans, Sibel
Atakan, Nilgün
Gököz, Özay
Karadağ, Ömer
Kılıçkap, Saadettin
Severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab
title Severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab
title_full Severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab
title_fullStr Severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab
title_full_unstemmed Severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab
title_short Severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab
title_sort severe progressive dermatomyositis in a patient with metastatic ovarian cancer using bevacizumab
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804122/
https://www.ncbi.nlm.nih.gov/pubmed/36204814
http://dx.doi.org/10.4103/ijp.ijp_11_22
work_keys_str_mv AT mentesogludilek severeprogressivedermatomyositisinapatientwithmetastaticovariancancerusingbevacizumab
AT gunaydinsibeldogan severeprogressivedermatomyositisinapatientwithmetastaticovariancancerusingbevacizumab
AT ersoyevanssibel severeprogressivedermatomyositisinapatientwithmetastaticovariancancerusingbevacizumab
AT atakannilgun severeprogressivedermatomyositisinapatientwithmetastaticovariancancerusingbevacizumab
AT gokozozay severeprogressivedermatomyositisinapatientwithmetastaticovariancancerusingbevacizumab
AT karadagomer severeprogressivedermatomyositisinapatientwithmetastaticovariancancerusingbevacizumab
AT kılıckapsaadettin severeprogressivedermatomyositisinapatientwithmetastaticovariancancerusingbevacizumab

Ejemplares similares